Buprenorphine and Naloxone
NDC 67296-2164, Buprenorphine and Naloxone, tablet, from Redpharm Drug.
- Product NDC
- 67296-2164
- Status
- Listed
- Labeler
- Redpharm Drug
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205601
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67296-2164-1 | 67296216401 | 12 TABLET in 1 BOTTLE, PLASTIC (67296-2164-1) |
| 67296-2164-6 | 67296216406 | 6 TABLET in 1 BOTTLE, PLASTIC (67296-2164-6) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/374530e2-3b2e-77d7-e063-6394a90a37c9
Use it
Look up 67296-2164 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67296-2164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.